Pattern is what separates them, and there is no blood test that will do it for you. Medication effects follow your injection and your dose increases, and they settle within weeks. Perimenopausal symptoms follow their own rhythm, fluctuate with your cycle while you still have one, and do not care what day you inject. Where a symptom sits on those two patterns is usually the most informative thing available.<\/p>\n
The evidence specifically on GLP-1 treatment during the menopausal transition is thin, and anyone telling you confidently how the two interact is going beyond what is established. What follows is about telling them apart rather than about how they combine.<\/p>\n
Several symptoms belong to both lists, which is why this is difficult:<\/p>\n
Fatigue.<\/strong> Common in perimenopause and common on a GLP-1, particularly if intake has dropped.<\/p>\n Sleep disruption.<\/strong> Central to perimenopause. Also affected by digestive discomfort and by eating patterns.<\/p>\n Mood changes and irritability.<\/strong> Both.<\/p>\n Difficulty concentrating.<\/strong> Both, and also a feature of eating too little.<\/p>\n Hair thinning.<\/strong> Both, and also associated with rapid weight loss.<\/p>\n Changes in appetite and weight.<\/strong> Obviously both.<\/p>\n Joint aches.<\/strong> More characteristically perimenopausal, but weight loss changes how you move.<\/p>\n Timing within the week.<\/strong> Semaglutide is injected weekly and its effects are strongest in the days after. If a symptom has developed a weekly rhythm that tracks your injection day, that rhythm belongs to the medication. Hormonal symptoms do not organize themselves around your injection schedule.<\/p>\n Relationship to dose changes.<\/strong> Medication effects spike after an increase and settle over the following one to three weeks. A symptom that appeared within days of a dose step and eased by week three fits the medication. A symptom that appeared at a stable dose with nothing changing does not. Our guide to semaglutide dose escalation<\/a> covers the timing of those steps, which is what you are matching your symptoms against.<\/p>\n Relationship to your cycle.<\/strong> If you are still cycling, even irregularly, symptoms that track your cycle are pointing at hormones. Perimenopausal symptoms also tend to fluctuate month to month in a way medication side effects generally do not.<\/p>\n There are also symptoms that belong clearly to one side. Hot flashes and night sweats are not features of GLP-1 treatment. Nausea concentrated after your injection is not a feature of perimenopause.<\/p>\n Two to four weeks of brief daily notes will answer more than any amount of reasoning. Each day, one line:<\/p>\n Then keep it going through your next dose increase. You are looking for what tracks what.<\/p>\n Consider this scenario: someone in perimenopause reports feeling terrible on a GLP-1 and is considering stopping. Three weeks of notes show fatigue and low mood at a fairly constant level unrelated to her injection day, and nausea concentrated on the two days after it. Those are two different problems with two different answers, and neither of them required stopping. Without the record, they had been a single undifferentiated sense of feeling awful.<\/p>\n Our guide to tracking your progress<\/a> covers building this habit alongside weight.<\/p>\n A lot of symptoms attributed to one or the other belong to a third cause: eating considerably less than your body needs.<\/p>\n The pattern is a cluster rather than a single symptom: persistent fatigue that sleep does not fix, feeling cold when others are comfortable, hair shedding, dizziness on standing, losing strength, difficulty concentrating.<\/p>\n If several of those are present, that explanation deserves checking before either of the other two, because it is the most addressable and because it can be mistaken for both. It is also worth knowing that iron and thyroid problems produce a similar picture and are worth excluding.<\/p>\n Say explicitly that you are trying to separate the two. It changes what your provider looks for, and it is a reasonable and answerable request.<\/p>\n If your GLP-1 prescriber and whoever manages your menopausal care are different people, tell each about the other. That gap is the most common reason this question goes unresolved.<\/p>\n Do not stop your medication to test it.<\/strong> If you and your provider decide a trial off treatment is worth it, that should be planned rather than improvised, because resuming is not simply picking up where you left off. Our guide on taking a break and restarting<\/a> covers why.<\/p>\n Do not attribute everything to hormones.<\/strong> It is the available explanation and it absorbs symptoms that have other causes.<\/p>\n Do not eat less because you feel worse.<\/strong> It makes several of these symptoms worse rather than better.<\/p>\n Do not wait for it to resolve.<\/strong> Both perimenopause and dose escalation can run for a long time.<\/p>\n Contact your provider if symptoms are severe enough to affect your daily life, if several signs of under-eating are present, if you have not had thyroid or iron levels checked, if hot flashes or sleep disruption are significant, or if your mood has been low for more than a couple of weeks.<\/p>\n If you are having thoughts of harming yourself, contact a healthcare professional promptly, or in the US call or text 988 to reach the Suicide and Crisis Lifeline.<\/p>\n Medication effects track your injection day and your dose increases and settle within weeks. Perimenopausal symptoms follow their own rhythm and fluctuate with your cycle. Hot flashes belong to one side and post-injection nausea to the other. Two to four weeks of one-line daily notes will separate most of it, and a third explanation, eating too little, is worth checking before either.<\/p>\nThe three features that separate them<\/h2>\n
The record that makes this answerable<\/h2>\n
\n
The third possibility<\/h2>\n
What to bring to your appointment<\/h2>\n
\n
What not to do<\/h2>\n
When to call<\/h2>\n
The short version<\/h2>\n